Beauty Health (SKIN)
NASDAQ: SKIN
· Real-Time Price · USD
1.62
0.01 (0.62%)
At close: May 30, 2025, 3:59 PM
1.70
4.87%
After-hours: May 30, 2025, 04:50 PM EDT
Beauty Health Revenue Breakdown
Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
---|---|---|---|---|
Consumables Revenue | 208.89M | 191.36M | 159.64M | 120.62M |
Consumables Revenue Growth | +9.16% | +19.87% | +32.35% | n/a |
Delivery Systems Revenue | 125.4M | 206.63M | 206.24M | 139.46M |
Delivery Systems Revenue Growth | -39.31% | +0.19% | +47.88% | n/a |
Revenue by Geography
Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
---|---|---|---|---|
Americas Revenue | 216.99M | 82.19M | 54.31M | 43.7M |
Americas Revenue Growth | +164.00% | +51.35% | +24.27% | n/a |
Asia Pacific Revenue | 45.67M | 88.09M | 68.33M | 46.96M |
Asia Pacific Revenue Growth | -48.16% | +28.92% | +45.50% | n/a |
Emea Revenue | 71.63M | n/a | n/a | n/a |
Emea Revenue Growth | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 59.6M | 58.28M | 61.06M | 61.89M | 62.55M | 61M | 67.7M | 78.1M | 69.08M | 67.49M | 63.55M | 72.47M | 62.67M | 62.1M | 49.65M | 70.62M | 27.91M | 26.89M | 17.59M | 11.6M | 24.89M | 23.32M |
Selling, General, and Administrative Revenue Growth | +2.27% | -4.55% | -1.35% | -1.04% | +2.53% | -9.90% | -13.32% | +13.06% | +2.35% | +6.21% | -12.31% | +15.63% | +0.92% | +25.07% | -29.69% | +153.05% | +3.79% | +52.82% | +51.71% | -53.40% | +6.73% | n/a |
Research and Development Revenue | 998K | 1.22M | 1.11M | 1.16M | 2.81M | 3M | 1.8M | 2.9M | 2.34M | 1.45M | 2.17M | 2.6M | 2.23M | 1.88M | 1.88M | 2.99M | 1.45M | 860K | 577K | 597K | 1.38M | 1.25M |
Research and Development Revenue Growth | -18.33% | +10.29% | -4.40% | -58.71% | -6.43% | +66.67% | -37.93% | +24.14% | +61.55% | -33.27% | -16.69% | +16.64% | +18.93% | -0.27% | -37.08% | +105.79% | +68.84% | +49.05% | -3.35% | -56.61% | +9.90% | n/a |
Sales and Marketing Revenue | 26.04M | 26.52M | 27.62M | 30.48M | 33.68M | 32.02M | 30.7M | 43M | 38.7M | 39.02M | 39.77M | 44.88M | 36.41M | 37.05M | 30.45M | 26.21M | 17.09M | 15.9M | 10.54M | 6.19M | 17.7M | 16.81M |
Sales and Marketing Revenue Growth | -1.83% | -3.96% | -9.39% | -9.51% | +5.18% | +4.32% | -28.60% | +11.11% | -0.83% | -1.88% | -11.39% | +23.28% | -1.74% | +21.68% | +16.16% | +53.34% | +7.53% | +50.82% | +70.40% | -65.04% | +5.30% | n/a |